BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Mark Sieczkarek Elected Chairman of the Board of Solta Medical, Inc. (SLTM)


6/12/2013 9:15:12 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HAYWARD, Calif., June 12, 2013 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that its Board of Directors has elected Mark M. Sieczkarek as its Chairman. Mr. Sieczkarek has been a member of the Board of Directors since July 2006 and has served as lead director since January 2008.  He has more than 18 years of leadership experience in the medical device industry and served as President and CEO of Conceptus, Inc. from 2003 to 2011.  Mr. Sieczkarek succeeds Stephen J. Fanning, who remains as President and Chief Executive Officer of Solta Medical.

"As part of our regular review of corporate governance and best practices, our Board of Directors has decided to separate the roles of Chairman and CEO," said Linda Graebner, Chairman of the Board's Nominating and Governance Committee.  "In electing Mark our Chairman, our shareholders will benefit from his previous public company experience as well as his seven years of service on Solta's Board of Directors. At the same time, we believe that this transition will enable Steve, our President and CEO, to focus on executing the plan to drive growth and returns from the Company's operations."

"From all perspectives, Solta has emerged as a leader in the growing aesthetics industry and our growth requires the Company to evolve in order to maximize the potential for shareholders, customers and employees," said Mr. Sieczkarek.  "I deeply appreciate the Board's confidence in electing me their chairman and look forward to working with the rest of the organization to realize the full potential of Solta Medical."

About Solta Medical, Inc.
Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative solutions with proven efficacy and safety backed by over 10 years of clinical study and research. The company offers aesthetic energy devices for skin resurfacing and rejuvenation, acne reduction, body contouring and skin tightening, as well as tools and accessories to optimize the latest liposuction techniques. The Solta Medical portfolio includes the well-known brands Thermage®, Fraxel®, Clear + Brilliant®, Liposonix®, Isolaz®, CLARO®, VASERlipo, VASERshape, VASERsmooth, VentX®, PowerX®, TouchView®, and Origins, which collectively make up a comprehensive platform to address a range of aesthetic skin and body issues. More than two and a half million procedures have been performed with Solta Medical's products around the world. Solta Medical is headquartered in Hayward, CA with field teams and regional offices worldwide.

SOURCE Solta Medical, Inc.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES